Company / Total Debt
Outlook Therapeutics, Inc. Total Debt History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.1M
FY2019
5-year range
$151.1K / $1.1M
FY2016-FY2019
Trend
+552.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt changed +553% YoY in FY2019, a notable deviation from the 3-year average annual change of +156%.
Based on SEC 10-K filings.
$1M in FY2019 with a 3-year CAGR of -21.6%.
Increased from $151,110 to $1M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -21.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -21.6%, indicating a declining trend.
- In FY2019, total debt increased 552.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | - | - |
| FY2019 | $1.1M | +552.5% |
| FY2018 | $165.0K | +9.2% |
| FY2017 | $151.1K | -93.2% |
| FY2016 | $2.2M | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026